Indivisible Partners’s CG Oncology CGON Stock Holding History

Indivisible Partners’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$318K	Buy	+4,490	New	+$330K	0.01%	558

Other funds holding CGON

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Renaissance Capital Stamford, Connecticut $145M AUM 53.16% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Strengthening Families & Communities LLC Boston, Massachusetts $459M AUM 29.64% 1-Year Est. Return

Indivisible Partners's CGON Position: Q3 2026 in Review

Indivisible Partners opened a new position in CG Oncology (CGON) in Q3 2026: 4,490 shares worth $318K. The stake represents 0.01% of the portfolio and ranks #558 among its holdings.

25 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

Indivisible Partners held 4,490 shares of CG Oncology worth $318K as of Q3 2026.
CG Oncology was a new Indivisible Partners position in Q3 2026.
CG Oncology made up 0.01% of Indivisible Partners's portfolio in Q3 2026, its #558 holding.
25 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on Indivisible Partners's 13F filing for Q3 2026, filed 26 Oct 2026.